Sex, Prescribing Practices and Guideline Recommended, Blood Pressure, and LDL Cholesterol Targets at Baseline in the BARI 2D Trial

Table 4

Achievement of clinical targets for HbA1c, blood pressure, and LDL-cholesterol at baseline in BARI 2D by sex.

Clinical target	% at clinical target			Odds ratio (95% CI)^†
	Female; ()	Male; ()	value	Unadjusted female versus male	Adjusted^† female versus male
HbA1c < 7%	31.9%	42.3%	<0.001	0.64 (0.53, 0.77)	0.71 (0.57, 0.88)
Blood pressure ≤ 130/80 mm Hg	45.0%	48.6%	0.12	0.87 (0.72, 1.04)	1.11 (0.92, 1.35)
LDL < 100 mg/dL	49.8%	63.1%	<0.001	0.58 (0.48, 0.69)	0.64 (0.53, 0.78)
Achieved all 3 target goals	10.9%	15.8%	0.002	0.65 (0.49, 0.86)	0.78 (0.58, 1.04)

All clinical targets were adjusted for the following common covariates: sex, age, race ethnicity, education, physical activity, cigarette smoking, duration of diabetes, and BMI. In addition, HbA1c was adjusted for a number of diabetes agents; lipids targets were adjusted for a number of lipids agents and CABG or PCI prior to randomization; blood pressure target was adjusted for a number of antihypertensive agents, CABG or PCI prior to randomization, and history of hypertension. The attainment on all 3 targets was controlled for a number of total drugs, CABG or PCI prior to randomization, and history of hypertension.